drugset / Trial / NCT01625897
A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the long-term safety, tolerability, and efficacy of MP-214 in patients with chronic phase or elderly schizophrenia.
Timeline
- Start
- 2012-05
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cariprazine | Small molecule | 1.5 mg | Oral |
| Subject | Cariprazine | Small molecule | 9 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 2 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 12 mg | Oral |